Literature Archives

Reinforces the need for IP involvement in structured, multidisciplinary mesothelioma care pathways.

Highlights the importance of centralized multidisciplinary care in managing complex pleural malignancies, which often require IP diagnostic and therapeutic interventions.

Clinicians must recognize that social media is a curated highlight reel rather than a clinical registry, highlighted by the finding that more than 99% of reviewed posts depicted successful diagnostic outcomes.

Flexible bronchoscopy is safe for elderly patients, with procedural complexity—not age—being the primary driver of risk

A validated, multicenter nomogram integrating the pleural fluid ADA-to-LDH ratio offers a superior, user-friendly tool for distinguishing tuberculous from malignant pleural effusions. This predictive model enhances diagnostic accuracy by improving upon individual biomarker performance.

Highlights the evolving landscape of lung cancer management, which informs the diagnostic and staging roles of interventional pulmonologists in the era of precision oncology.

Relevant for IP clinicians involved in the diagnostic workup and tissue acquisition for molecular profiling in lung cancer patients.

Essential reading for IP practitioners to understand and mitigate risks associated with EBUS-TBNA and cryobiopsy.

While BAL cellular profiles are a vital supportive tool—especially for identifying lymphocytosis in non-fibrotic lung diseases—they lack the standalone specificity to definitively diagnose fibrotic ILDs and must be integrated into a multidisciplinary discussion.

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) provides a viable, minimally invasive source of high-quality tissue for generating patient-derived lung cancer models, effectively bridging the gap between diagnostic sampling and precision oncology.

Helps in clinical decision-making regarding the timing of surgical or IP intervention for persistent air leaks.

First-line indwelling pleural catheter (IPC) insertion efficiently manages all malignant pleural effusions, allowing for subsequent talc pleurodesis in suitable patients while avoiding the need for pre-assessment of lung expansion. A real-world study showed that this approach achieves high success rates for both immediate talc therapy and long-term symptom-guided drainage.